The case for including bowel urgency in toxicity reporting after pelvic cancer treatmentCitation formats

  • External authors:
  • Caroline C. Henson
  • Carmel N. Anandadas
  • Lisa H. Barraclough
  • Ric Swindell
  • Susan E. Davidson

Standard

The case for including bowel urgency in toxicity reporting after pelvic cancer treatment. / Henson, Caroline C.; Anandadas, Carmel N.; Barraclough, Lisa H.; Swindell, Ric; West, Catharine M L; Davidson, Susan E.

In: JNCCN Journal of the National Comprehensive Cancer Network, Vol. 11, No. 7, 01.07.2013, p. 827-833.

Research output: Contribution to journalArticlepeer-review

Harvard

Henson, CC, Anandadas, CN, Barraclough, LH, Swindell, R, West, CML & Davidson, SE 2013, 'The case for including bowel urgency in toxicity reporting after pelvic cancer treatment', JNCCN Journal of the National Comprehensive Cancer Network, vol. 11, no. 7, pp. 827-833. <http://www.jnccn.org/content/11/7/827.full.pdf+html>

APA

Henson, C. C., Anandadas, C. N., Barraclough, L. H., Swindell, R., West, C. M. L., & Davidson, S. E. (2013). The case for including bowel urgency in toxicity reporting after pelvic cancer treatment. JNCCN Journal of the National Comprehensive Cancer Network, 11(7), 827-833. http://www.jnccn.org/content/11/7/827.full.pdf+html

Vancouver

Henson CC, Anandadas CN, Barraclough LH, Swindell R, West CML, Davidson SE. The case for including bowel urgency in toxicity reporting after pelvic cancer treatment. JNCCN Journal of the National Comprehensive Cancer Network. 2013 Jul 1;11(7):827-833.

Author

Henson, Caroline C. ; Anandadas, Carmel N. ; Barraclough, Lisa H. ; Swindell, Ric ; West, Catharine M L ; Davidson, Susan E. / The case for including bowel urgency in toxicity reporting after pelvic cancer treatment. In: JNCCN Journal of the National Comprehensive Cancer Network. 2013 ; Vol. 11, No. 7. pp. 827-833.

Bibtex

@article{6869d0e470df481a9c21afbfe586d0d6,
title = "The case for including bowel urgency in toxicity reporting after pelvic cancer treatment",
abstract = "Bowel toxicity is a major complication of cancer treatment, and its accurate reporting is important for assessing outcomes. The NCI's Common Terminology Criteria for Adverse Events (CTCAE) is the preferred method for capturing adverse events after all cancer treatments, particularly within clinical trials. However, the CTCAE version 4 does not include urgency of defecation as an item, despite this being one of the most common and persistent adverse consequences of treatment of pelvic cancers. The importance of bowel urgency to patients is well documented, and this treatment effect has a negative impact on social function and quality of life. Bowel urgency is also important clinically because it may represent significant underlying problems. This article presents the case for including patient reported assessment of bowel urgency as an independent item in cancer treatment adverse event reporting. Copyright {\textcopyright} 2013 by the National Comprehensive Cancer Network. All rights reserved.",
author = "Henson, {Caroline C.} and Anandadas, {Carmel N.} and Barraclough, {Lisa H.} and Ric Swindell and West, {Catharine M L} and Davidson, {Susan E.}",
note = "RP-PG-0611-20008, Department of Health, United Kingdom",
year = "2013",
month = jul,
day = "1",
language = "English",
volume = "11",
pages = "827--833",
journal = "JNCCN Journal of the National Comprehensive Cancer Network",
issn = "1540-1405",
publisher = "Harborside Press",
number = "7",

}

RIS

TY - JOUR

T1 - The case for including bowel urgency in toxicity reporting after pelvic cancer treatment

AU - Henson, Caroline C.

AU - Anandadas, Carmel N.

AU - Barraclough, Lisa H.

AU - Swindell, Ric

AU - West, Catharine M L

AU - Davidson, Susan E.

N1 - RP-PG-0611-20008, Department of Health, United Kingdom

PY - 2013/7/1

Y1 - 2013/7/1

N2 - Bowel toxicity is a major complication of cancer treatment, and its accurate reporting is important for assessing outcomes. The NCI's Common Terminology Criteria for Adverse Events (CTCAE) is the preferred method for capturing adverse events after all cancer treatments, particularly within clinical trials. However, the CTCAE version 4 does not include urgency of defecation as an item, despite this being one of the most common and persistent adverse consequences of treatment of pelvic cancers. The importance of bowel urgency to patients is well documented, and this treatment effect has a negative impact on social function and quality of life. Bowel urgency is also important clinically because it may represent significant underlying problems. This article presents the case for including patient reported assessment of bowel urgency as an independent item in cancer treatment adverse event reporting. Copyright © 2013 by the National Comprehensive Cancer Network. All rights reserved.

AB - Bowel toxicity is a major complication of cancer treatment, and its accurate reporting is important for assessing outcomes. The NCI's Common Terminology Criteria for Adverse Events (CTCAE) is the preferred method for capturing adverse events after all cancer treatments, particularly within clinical trials. However, the CTCAE version 4 does not include urgency of defecation as an item, despite this being one of the most common and persistent adverse consequences of treatment of pelvic cancers. The importance of bowel urgency to patients is well documented, and this treatment effect has a negative impact on social function and quality of life. Bowel urgency is also important clinically because it may represent significant underlying problems. This article presents the case for including patient reported assessment of bowel urgency as an independent item in cancer treatment adverse event reporting. Copyright © 2013 by the National Comprehensive Cancer Network. All rights reserved.

M3 - Article

C2 - 23847219

VL - 11

SP - 827

EP - 833

JO - JNCCN Journal of the National Comprehensive Cancer Network

JF - JNCCN Journal of the National Comprehensive Cancer Network

SN - 1540-1405

IS - 7

ER -